Circulating tumor DNA analysis predicts recurrence and avoids unnecessary adjuvant chemotherapy in I–IV colorectal cancer

Background: Circulating tumor DNA (ctDNA) has emerged as a biomarker that can define the risk of recurrence after curative-intent surgery for patients with colorectal cancer (CRC). However, beyond the predictive power of postoperative ctDNA detection, the efficacy and potential limitations of ctDNA...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Wenhua Fan, Zhiyuan Xia, Rongrong Chen, Dagui Lin, Fang Li, Yang Zheng, Jiongyong Luo, Yuanyuan Xiong, Pengli Yu, Wei Gao, Yuhua Gong, Feiran Zhang, Sen Zhang, Liren Li
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	SAGE Publishing 2024-01-01
Sarja:	Therapeutic Advances in Medical Oncology
Linkit:	https://doi.org/10.1177/17588359231220607
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!